Immunome, Inc. (IMNM) vs Progyny, Inc. (PGNY)
A side-by-side comparison of Immunome, Inc. and Progyny, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMNM
Immunome, Inc.
$19.69HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
PGNY
Progyny, Inc.
$26.01HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — IMNM vs PGNY
growth of $100 · dividends reinvested · last 6yIMNM +57.4% (+7.9%/yr)PGNY -10.4% (-1.8%/yr)IMNM compounded faster over this window
IMNM PGNY
IMNM vs PGNY: by the numbers
- •PGNY is the larger company ($2.04B vs $1.88B market cap).
- •PGNY is profitable (6.00% net margin) while IMNM runs a net loss (-3059.99%).
Metrics side by side
Valuation
| Metric | IMNM | PGNY |
|---|---|---|
| P/E ratio | N/A | 28.27 |
| Forward P/E | N/A | 20.22 |
| PEG ratio | N/A | 4.22 |
| P/S ratio | N/A | 1.55 |
| P/B ratio | 3.58 | 4.50 |
| EV / EBITDA | N/A | 16.02 |
| FCF yield | N/A | 10.70% |
Profitability
| Metric | IMNM | PGNY |
|---|---|---|
| Gross margin | 57.43% | 24.57% |
| Operating margin | -3084.76% | 8.55% |
| Net margin | -3059.99% | 6.00% |
| ROE | -48.43% | 17.35% |
| ROIC | -51.06% | 15.47% |
Growth (annualized)
| Metric | IMNM | PGNY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 23.84% |
| EPS CAGR (5Y) | N/A | 4.72% |
| FCF CAGR (5Y) | N/A | 73.48% |
| Total return CAGR (5Y) | 2.88% | -14.83% |
Frequently asked
- Is IMNM or PGNY more profitable?
- PGNY runs the higher net margin — IMNM at -3059.99% versus PGNY at 6.00%.
- How have IMNM and PGNY total returns compared?
- Over the past 5 years, IMNM delivered 2.88% and PGNY delivered -14.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Progyny P/E ratioImmunome ROEProgyny ROEImmunome operating marginProgyny operating marginImmunome revenue growthProgyny revenue growthImmunome free cash flowProgyny free cash flow
Immunome & Progyny appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.